Group 1: ETF Performance - As of January 21, the Medical Equipment ETF (159873) saw a net subscription of 3 million units, with a turnover rate of 8.04% and a transaction volume of 18.88 million yuan [1] - The Medical Equipment ETF reached a new high with a total size of 379 million units [1] - The Medical Equipment ETF has experienced continuous net inflows over the past 10 days, totaling 119 million yuan [1] Group 2: Innovation Drug ETF Highlights - The Innovation Drug ETF Tianhong (517380) achieved a new size of 1.88 billion yuan and a total of 2.36 billion units, both marking new highs since its inception [2] - The Innovation Drug ETF has seen continuous net inflows for 12 days, accumulating 426 million yuan [3] Group 3: Market Trends and Events - A new guideline was released by the National Healthcare Security Administration on January 20, focusing on pricing for surgical robots and other medical services, establishing 37 pricing projects and 5 additional items [6] - The JPM 2026 conference highlighted the strength of Chinese innovative drugs, with significant collaborations between Chinese companies and multinational giants, indicating a shift from asset export to global participation [7] Group 4: Institutional Insights - According to Founder Securities, the implementation of the new pricing guideline will promote the clinical adoption of innovative technologies and drive demand for terminal equipment and surgical assistance [8] Group 5: Product Features - The Medical Equipment ETF (159873) has a high content of brain-computer interface stocks, accounting for over 19%, and includes nearly 80% of stocks from the Sci-Tech Innovation Board and the Growth Enterprise Market [4]

Group 1 - The medical device sector is experiencing volatility, with the medical device ETF (159873) achieving a trading volume of 48.6 million yuan and a turnover rate exceeding 26%, leading in its category [1] - The ETF has seen a net inflow of 57 million units, continuing a trend of net inflows over the past six days, totaling over 60 million yuan, with a net flow rate of 60% in the last ten days [1] - The semiconductor sector is showing strong growth, with the semiconductor ETF Tianhong (159310) index rising by 3.08% [1] Group 2 - The medical device ETF (159873) tracks the healthcare index and has a high concentration of brain-computer interface stocks, accounting for over 17% of its holdings, with nearly 80% of its components from the Sci-Tech Innovation Board and the Growth Enterprise Market [2] - The ETF is expected to benefit from domestic innovation, accelerated exports, and new technologies, leading to a potential comprehensive valuation recovery [2] - The semiconductor ETF Tianhong (159310) tracks the semiconductor industry index and covers key areas such as chip design, manufacturing, and packaging testing, directly benefiting from domestic substitution and technological breakthroughs in the semiconductor industry [2]